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TO THE EDITOR
Although it is possible to isolate kerati-
nocyte stem cells (KSCs) of the human
interfollicular epithelium by virtue of
their composite cell surface phenotype
(a6 integrin and CD71; Li et al., 1998;
Schluter et al., 2011), it remains difficult
to visualize them in situ within the skin.
Although murine interfollicular KSCs
can be visualized in situ by DNA-
labeling protocols combined with long
chase periods (termed DNA label-
retaining cells or LRCs; Bickenbach,
1981), this approach is not possible in
humans for ethical reasons. Our aim
was to identify single markers for
human interfollicular KSCs at the
protein level, by mining microarray
data previously generated by us to
identify genes preferentially expressed
by KSCs compared with their more
committed progeny (Schluter et al.,
2011). Interfollicular epidermal cells
from neonatal human skin tissue
can be resolved into quiescent KSCs,
cycling committed progenitor (CP) or
transient-amplifying (TA) cells, and
early differentiating (D) cells on the
basis of their cell surface phenotype,
i.e., a6
briCD71dim, a6
briCD71bri, and
a6
dim, respectively (Li et al., 1998).
Importantly, functional long-term tissue
reconstitution assays confirmed the
identity of a6
briCD71dim cells as a
bona fide stem cell population,
given their potency in reconstituting
human interfollicular epidermis for
up to 10 weeks from as little as
100 cells (Schluter et al., 2011).
Further, molecular characterization
by microarray validated their quiescent
nature (Schluter et al., 2011). Notably,
KSCs overexpressed negative regulators
of key signaling pathways including
Wnt, insulin, sonic hedgehog, and
transforming growth factor beta, shown
in Figure 1a (taken from Schluter et al.,
2011). Among the Wnt signalingAccepted article preview online 28 January 2013
Abbreviations: CP, committed progenitor; D, differentiating cell; K, keratin; KSC, keratinocyte stem cell;
LRC, label-retaining cell; TA, transient amplifying; WNT3A, activating Wnt signal; WIF1, Wnt inhibitory
factor-1
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pathway inhibitors expressed by KSCs
were Sfrp-1, Dkk-3, and (Wnt inhibitory
factor-1) WIF1 (Figure 1a). Notably,
WIF1 was the single most overexpressed
gene in KSCs (Schluter et al., 2011)—its
differential expression in KSCs was
confirmed by reverse transcription–PCR
(Figure 1b).
These data suggested that WIF1 may
be an excellent marker for interfollicular
KSCs of human skin. We performed
dual immunofluorescence staining in
human neonatal and adult breast skin
for WIF1, and keratin (K)14 or K15—
markers of basal keratinocytes and a6
integrin—a basement membrane mar-
ker. Single basal keratinocytes coexpres-
sing WIF1 and K14/K15 were found
scattered throughout the basal layer in
neonatal foreskin, but were more widely
expressed in adult skin (Figure 1c–h;
arrows). In addition, almost all dermal
cells, an active site for Wnt signaling,
were also positive for WIF1 (Figure
1c–h). WIF1 immunostaining on cytos-
pins of a6
briCD71dim/KSC, a6
briCD71bri/
TA or CP, and a6
dim/D cells confirmed
highest WIF1 protein expression in KSCs
but not the cycling TA/CPs qualitatively
(Figure 1k–m), and quantitatively
(Figure 1n). Although the a6
dim differen-
tiating fraction has a higher level of
WIF1 than TA/CP cells in cytospins, this
population is somewhat heterogeneous,
containing many suprabasal cells that
are clearly WIF1 positive. Notably, cells
positive for both K10 and WIF1 were
consistently located in the suprabasal
layers in both neonatal and adult skin
in situ (Figure 1g and h). Further, dual
staining for Ki67 and WIF1 in adult skin
revealed that Ki67-positive cells do not
express WIF1 (Figure 1c). Thus, WIF1 is
highly expressed in non-cycling cells,
indicating a role in negatively regulating
keratinocyte proliferation.
To further demonstrate that WIF1 is a
bona fide interfollicular KSC marker, we
sought to determine whether slow-
cycling LRCs coexpressed WIF1 in
human skin. LRCs can be visualized in
human skin in situ in grafts on immu-
nodeficient mice (Lyle et al., 1998), or
alternately in long-term organotypic
cultures of human keratinocytes,
with an incidence of o1% after 6
weeks (Muffler et al., 2008). Using
the latter approach validated by us
previously, we stained histological
sections of iododeoxyuridine-labeled
long-term organotypic cultures for
iododeoxyuridine and WIF1. All
iododeoxyuridine-positive epidermal
cells were also WIF1 positive
(Figure 2f–k), whereas cycling Ki67-
positive cells were not (Figure 2a and
b), providing supportive evidence that
WIF1 protein is an excellent marker for
quiescent stem cells of the interfollicular
epidermis. Notably, there was an
absence of WIF1-positive cells in the
hyperproliferative basal layer of organo-
typic cultures in the early 2-week
post-labeling time points, as evidenced
by the presence of many Ki67-positive
cells (Figure 2a and c). WIF1-positive
basal cells were detectable by 6 weeks
(Figure 2b and d), a time point
corresponding with the establishment
of single LRCs (Muffler et al., 2008),
although none of these were
Ki67 positive. Notably, none of the
WIF1-positive cells in the basal layer
of organotypic cultures were K10
positive at all time points analyzed,
and double-positive cells were only
localized suprabasally (Figure 2c–e), con-
firming our observations in skin tissue.
The functional significance of WIF1
overexpression in interfollicular KSCs is
of great interest given the current evi-
dence for an increase in Wnt signaling
in wound healing, psoriasis, and basal
cell carcinomas (Gudjonsson et al.,
2010; Arwert et al., 2012). Indeed,
activating mutations in Wnt pathway
family members contribute to the
progression of several major human
cancers (Moon et al., 2004).
Surprisingly, Wnt/beta-catenin signaling
is reportedly crucial for the
development of epidermal appendages,
but not the interfollicular epidermis
(Huelsken et al., 2001; Nguyen et al.,
2009). However, abundant expression
of wnt 5a, one of several wnt ligands,
has been reported in normal adult
skin (Pourreyron et al., 2012). Immuno-
staining of both neonatal and adult skin
also revealed abundant expression of
the canonical wnt ligand activating
Wnt signal (Wnt3A) throughout the
epithelium and in some dermal cells
(Figure 1i and j). Given the observation
that WIF1 is expressed in quiescent
LRCs of adult human skin and
differentiating keratinocytes, we next
addressed the possibility that it may
negatively regulate keratinocyte prolif-
eration in the presence of Wnt3A.
Immunostaining cultured keratino-
cytes for WIF1 revealed that its expres-
sion was lost in proliferating cultured
keratinocytes (data not shown), consis-
tent with the mRNA data shown in
Figure 1a and b (TA/CP fraction). There-
fore, we looked at the effects of exogen-
ous WIF1 on keratinocytes. We
synchronized the cell cycle activity of
neonatal human foreskin keratinocytes
in culture using the double thymidine
block method, arresting them in late G1
phase (Figure 2l). Subsequent treatment
of arrested keratinocytes with 20 ng of
Wnt3A for 2 hours at 37 1C released
them from the G1 arrest, i.e., a decrease
in the number of cells in G1 of 26% and
an increase in cells in % SþG2M of
19% (Figure 2m). Whereas treating cells
with 3mg WIF1 alone did not maintain
the cells in G1, simultaneous treatment
with WIF1 and the Wnt ligand
Wnt3A blocked the re-entry of
cells into S-phase (16%, Figure 2n, com-
pared with 25% with Wnt3A
alone, Figure 2m). Concomitantly, the
combined Wnt3A and WIF1 treatment
resulted in the accumulation of cells in
G1 (44 vs. 24% in Wnt3A control) and a
decrease of cells in G2M (16 vs. 31% in
Wnt3A control; Figure 2m and n).
These data show that WIF1 negatively
regulates cell cycle progression in
human keratinocytes in the presence of
Wnt ligands, indicating a potential
role in keratinocyte quiescence and
differentiation.
It has been reported that WIF1
achieves G1 cell cycle arrest in cancer
cells, by the transcriptional downregu-
lation of cell cycle regulatory Wnt
target genes such as c-myc and Skp2
(S-phase kinase associated protein 2)
(Tang et al., 2009). c-myc is a repressor
of p21/WAF1 (van de Wetering et al.,
2002), whereas Skp2 regulates p27/
Kip1 degradation (Gstaiger et al.,
2001)—thus, downregulation of c-myc
and Skp2 results in accumulation of
p21 and p27 (Tang et al., 2009)—
two major regulators of CDK2, the
main cyclin-dependent kinase
controlling G1- to S-phase progression
(Pfeuty et al., 2008). Consistent with
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Figure 1. Identification of WIF1 as a marker for keratinocyte stem cells (KSCs). (a) Heatmap showing differential expression of Wnt signaling–related genes in KSCs
(a6
briCD71dim), transient-amplifying/committed progenitor (TA/CP) cells (a6
briCD71bri), and in differentiating (a6
dim/D) keratinocytes. Published previously, in part, in
Schluter et al. (2011) and reproduced with permission from Stem Cells. (b) Real-time PCR of Wnt inhibitory factor-1 (WIF1) and Wnt target genes c-myc and Skp2
(S-phase kinase associated protein 2) in KSCs, TA, and differentiating (D) cell fractions, displayed as fold change relative to the TA/CP population. (c–h) Dual immuno-
fluorescence staining of tissue sections of neonatal foreskin and adult breast skin for WIF1 in red and Ki67 (c); the basal cell keratin 14 (K14, d), keratin 15 (K15, e), alpha 6
integrin (f), or keratin 10 (K10, g, h), all in green. Arrows in g indicate WIF1-positive/K10-negative basal keratinocytes, whereas arrowhead indicates a WIF1- and
K10-positive cell close to detaching from the basement membrane in neonatal skin. In h, arrow indicates WIF1-positive/K10-negative basal keratinocyte; arrowhead
indicates a K10-positive but WIF1-negative cell in the process of leaving the basal layer; dotted arrow indicate a K10- and WIF1-positive keratinocyte predominantly
in the suprabasal layer of adult skin. Nuclei counterstained with 4’,6-diamidino-2-phenylindole (DAPI). (i–j) Adult breast skin (i) and neonatal foreskin (j) stained for Wnt3A.
(k–m) Cytospins of the sorted KSCs (k), TA/CP (l), and D keratinocyte populations (m) immunofluorescently stained for WIF1 (red); nuclei counterstained with DAPI.
(n) Quantification of WIF1 cytospin staining in KSCs, TA/CP, and D cells from a total of 43, 40, and 52 cells, respectively. *P-valueo0.05; **P-valueo0.01;
***P-valueo0.001. All experiments were performed in triplicate, except the cytospin staining, which was performed in duplicate. WIF1 was visualized using anti-human
WIF1 antibody (R&D, Systems, MN) at a dilution of 1:100. Wnt3A was visualized using anti-human Wnt3A (R&D; MAB 1324 at a 1:50 dilution. Bar¼ 50mm.
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Figure 2. Wnt inhibitory factor-1 (WIF1) is expressed in slow-cycling label-retaining cells (LRCs) and not in cycling cells in human skin, and regulates
keratinocyte proliferation. (a, b) Dual immunofluorescence staining of sections of short-term and long-term iododeoxyuridine (IdU)-labeled organotypic cultures
(OCs) for Ki67 (green) and WIF1 (red) at 2 and 6 weeks. (c–e) OCs dual-stained for K10 (green) and WIF1 (red) at 2, 6, and 10 weeks. Arrows indicate
WIF1-positive cells within the basal layer, which are keratin 10 (K10) negative. (f–k) Two independent OCs (f, g) dual-stained with anti-IdU (blue) and
WIF1 (red) at 8 weeks. Arrows indicate LRCs that co-express WIF1. (h–k) Nuclear DAPI counterstaining (green – h, j) and phase contrast images (i, k) of the
OCs shown in panel f and g. (i–n) Cell cycle analysis of synchronised keratinocytes following propidium iodine (PI) staining: controls (l), after treatment with
20ng Wnt3A ligand for 2 hours (m), or with 20ng Wnt3Aþ 3mg WIF1 (n). (o) Western blot analysis of keratinocyte lysates in controls, or Wnt3A and Wnt3A/WIF1
treated keratinocytes probed for p21 and tubulin (control). The data shown are representative of three replicate experiments. (p) Quantification of p21
western blots normalized to tubulin expressed as percentage of HFK starved controls. *P-valueo0.05; **P-valueo0.01. Bar¼ 50 mm.
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this, we observed that the downstream
effectors of the Wnt pathway, i.e.,
c-myc and Skp2 were not expressed
in KSCs by reverse transcription–PCR
(Figure 1b). Further, probing cell
lysates of WIF1-arrested keratinocytes
in western blots revealed that Wnt3A/
WIF1 treatment resulted in increased
p21 protein levels (Figure 2o) demon-
strable quantitatively (Figure 2p).
Thus, WIF1 may achieve its cell cycle
arrest in keratinocytes at least in
part through derepression of p21
transcription.
In conclusion, we report that WIF1
is, to our knowledge, previously unre-
ported as a marker of interfollicular
KSCs, and that it inhibits cell cycle
progression in human keratinocytes
even in the presence of activating
Wnt signals (Wnt3A). Although cano-
nical Wnt signaling appears to be dis-
pensable during development in the
interfollicular epidermis (Huelsken
et al., 2001; Nguyen et al., 2009), our
data suggest that inhibition of Wnt
signaling may be required for keeping
interfollicular stem cells quiescent and
differentiating cells from proliferating
during homeostasis.
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Serum Gastrin-Releasing Peptide Levels Correlate with
Pruritus in Patients with Atopic Dermatitis
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TO THE EDITOR
Bombesin and two major bombesin-like
peptides in mammals, gastrin-releasing
peptide (GRP) and neuromedin B, have
been shown to elicit various physiological
effects. GRP elicits gastrin release and
regulates gastric acid secretion and motor
function (Merali et al., 1999). This peptide
is also involved in the biology of the
circadian system. Interestingly, intra-
dermal injections of GRP elicit scratch-
ing in mice (Andoh et al., 2011). GRP is
expressed in a subset of peptidergic dorsal
root ganglion neurons, whereas GRP
receptor (GRPR) is expressed in lamina I
of the dorsal spinal cord (Sun and Chen,
2007). When lamina I neurons expressing
GRPR in the spinal cord were selectively
ablated, the mice showed profound
scratching deficits in response to all of
the itching stimuli tested, irrespective of
their histamine dependence (Sun et al.,
2009). These data support the labeled lineAccepted article preview online 25 January 2013
Abbreviations: AD, atopic dermatitis; GRP, gastrin-releasing peptide; GRPR, GRP receptor; PGP, protein
gene product; VAS, visual analog scale
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